<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:29a83c33-4b95-44f3-81ae-1927357eac29,g:3920e3b9-a6c8-4e33-b6fa-f32db04e1a50-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.westpharma.com/role/CoverPage" xlink:type="simple" xlink:href="wst-20200930.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="simple" xlink:href="wst-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_17332409-ccf3-4806-a152-225ffb6ef41e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_36b5e454-ed8b-4721-928a-0cf09c7d3200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_17332409-ccf3-4806-a152-225ffb6ef41e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_36b5e454-ed8b-4721-928a-0cf09c7d3200" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_715e8d68-5dfc-4358-a689-445f9a679a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_17332409-ccf3-4806-a152-225ffb6ef41e" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_715e8d68-5dfc-4358-a689-445f9a679a1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_513a4ac1-0465-4ae8-97f7-10e80dc072b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ce25b0dc-dcd2-4ac5-9070-7956c1ae35cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_513a4ac1-0465-4ae8-97f7-10e80dc072b0" xlink:to="loc_us-gaap_OperatingIncomeLoss_ce25b0dc-dcd2-4ac5-9070-7956c1ae35cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_1d6a326f-ad40-4383-b26a-55dd21b6ce61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_513a4ac1-0465-4ae8-97f7-10e80dc072b0" xlink:to="loc_us-gaap_InterestExpense_1d6a326f-ad40-4383-b26a-55dd21b6ce61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_6e2b8efe-3706-482a-b60a-49f6f822d26c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_513a4ac1-0465-4ae8-97f7-10e80dc072b0" xlink:to="loc_us-gaap_InvestmentIncomeNet_6e2b8efe-3706-482a-b60a-49f6f822d26c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_eb9ed6fe-6e35-41a4-b5fd-242c2c0acbdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_513a4ac1-0465-4ae8-97f7-10e80dc072b0" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_eb9ed6fe-6e35-41a4-b5fd-242c2c0acbdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f5b65686-1920-4b10-b6cf-912359074e23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_7ba7a354-8458-43a3-a183-4b764211335f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f5b65686-1920-4b10-b6cf-912359074e23" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_7ba7a354-8458-43a3-a183-4b764211335f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a7b1c152-befe-48e7-8f4d-0ae6a5052e79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f5b65686-1920-4b10-b6cf-912359074e23" xlink:to="loc_us-gaap_GrossProfit_a7b1c152-befe-48e7-8f4d-0ae6a5052e79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6c431cbf-9530-4153-b6b0-1b0641e402c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f5b65686-1920-4b10-b6cf-912359074e23" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6c431cbf-9530-4153-b6b0-1b0641e402c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_7776908b-19e5-418f-a2e9-b81d90e0720c" xlink:href="wst-20200930.xsd#wst_OtherIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f5b65686-1920-4b10-b6cf-912359074e23" xlink:to="loc_wst_OtherIncomeExpense_7776908b-19e5-418f-a2e9-b81d90e0720c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dbd80a45-b3d5-4f58-b921-4264d2a00944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ad40601c-a025-40c6-86cc-4fac4f5c7bc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_dbd80a45-b3d5-4f58-b921-4264d2a00944" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ad40601c-a025-40c6-86cc-4fac4f5c7bc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5cc5b377-8358-4e55-a7ef-323c6ca39617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_dbd80a45-b3d5-4f58-b921-4264d2a00944" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5cc5b377-8358-4e55-a7ef-323c6ca39617" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a4dd5e29-0c84-4874-8f3d-535a1af7fe59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_dbd80a45-b3d5-4f58-b921-4264d2a00944" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_a4dd5e29-0c84-4874-8f3d-535a1af7fe59" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="wst-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_eac15341-b8c9-427b-b217-998af464107f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_f28b2706-0b00-4818-927e-71b06cf514f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_eac15341-b8c9-427b-b217-998af464107f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_f28b2706-0b00-4818-927e-71b06cf514f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_d8b80ba5-66c0-4835-9381-7bd1913c3517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_eac15341-b8c9-427b-b217-998af464107f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_d8b80ba5-66c0-4835-9381-7bd1913c3517" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_dd784149-b921-4a57-a16d-8bbc6da0aa3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_eac15341-b8c9-427b-b217-998af464107f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_dd784149-b921-4a57-a16d-8bbc6da0aa3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_76768b97-3112-4409-b22a-5ac9b35c342b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cbb3b4b0-ef3a-4c2a-bd3a-f95727e23632" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_76768b97-3112-4409-b22a-5ac9b35c342b" xlink:to="loc_us-gaap_NetIncomeLoss_cbb3b4b0-ef3a-4c2a-bd3a-f95727e23632" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c072f200-e72a-445f-a64c-9512f942daf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_76768b97-3112-4409-b22a-5ac9b35c342b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c072f200-e72a-445f-a64c-9512f942daf6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITEDParenthetical" xlink:type="simple" xlink:href="wst-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITEDParenthetical"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITEDParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="wst-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c9d30947-2d7d-48a4-a7af-951a79b95214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8df518e9-3839-4ed8-90a5-175e622551fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c9d30947-2d7d-48a4-a7af-951a79b95214" xlink:to="loc_us-gaap_AssetsCurrent_8df518e9-3839-4ed8-90a5-175e622551fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_bdca948a-e7fd-4eaa-b9c5-044d61546d1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c9d30947-2d7d-48a4-a7af-951a79b95214" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_bdca948a-e7fd-4eaa-b9c5-044d61546d1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9d7278d7-3c15-4e71-b6eb-f01a8049f34d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c9d30947-2d7d-48a4-a7af-951a79b95214" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9d7278d7-3c15-4e71-b6eb-f01a8049f34d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_d651e8ed-6ec2-4111-b56f-539b5d34d205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c9d30947-2d7d-48a4-a7af-951a79b95214" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_d651e8ed-6ec2-4111-b56f-539b5d34d205" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_17be3e88-15d6-4cc2-a558-95aab8b86814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c9d30947-2d7d-48a4-a7af-951a79b95214" xlink:to="loc_us-gaap_Goodwill_17be3e88-15d6-4cc2-a558-95aab8b86814" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_154c3112-7aeb-488a-800b-9bb44c2b5420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c9d30947-2d7d-48a4-a7af-951a79b95214" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_154c3112-7aeb-488a-800b-9bb44c2b5420" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_9d4643d0-e192-4346-a7cb-e2b4ee184479" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c9d30947-2d7d-48a4-a7af-951a79b95214" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_9d4643d0-e192-4346-a7cb-e2b4ee184479" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_073490b4-f5b4-4649-ac5b-31f6e11cff21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c9d30947-2d7d-48a4-a7af-951a79b95214" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_073490b4-f5b4-4649-ac5b-31f6e11cff21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_cfafc617-aa39-4322-ad33-1186ee6f7e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c9d30947-2d7d-48a4-a7af-951a79b95214" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_cfafc617-aa39-4322-ad33-1186ee6f7e6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_07a838da-99a0-43cd-b072-22499656927f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_a2560ebb-7bbc-47d1-b17e-8655ce230eb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_07a838da-99a0-43cd-b072-22499656927f" xlink:to="loc_us-gaap_DebtCurrent_a2560ebb-7bbc-47d1-b17e-8655ce230eb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_bfb3818b-9fc5-4cca-a826-ebe9347db0bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_07a838da-99a0-43cd-b072-22499656927f" xlink:to="loc_us-gaap_AccountsPayableCurrent_bfb3818b-9fc5-4cca-a826-ebe9347db0bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_c6610feb-8d76-49a4-b66e-4ddbf7b2acb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_07a838da-99a0-43cd-b072-22499656927f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_c6610feb-8d76-49a4-b66e-4ddbf7b2acb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_7cf4cf14-a5d7-4795-8b16-5a81554e25f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherEmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_07a838da-99a0-43cd-b072-22499656927f" xlink:to="loc_us-gaap_OtherEmployeeRelatedLiabilitiesCurrent_7cf4cf14-a5d7-4795-8b16-5a81554e25f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_627ec65c-672c-4ed7-b6f1-65a9706aa495" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_07a838da-99a0-43cd-b072-22499656927f" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_627ec65c-672c-4ed7-b6f1-65a9706aa495" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c8ed0437-ce81-430e-b08a-92724ef08d94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_07a838da-99a0-43cd-b072-22499656927f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c8ed0437-ce81-430e-b08a-92724ef08d94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_fc31c54f-ccc7-46a8-a9b4-46ebe13e047a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_07a838da-99a0-43cd-b072-22499656927f" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_fc31c54f-ccc7-46a8-a9b4-46ebe13e047a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9e6771ca-201d-4e5e-8209-cef9fa30b9a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f0d03a6e-b6fc-4fce-8286-6255823eebdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9e6771ca-201d-4e5e-8209-cef9fa30b9a5" xlink:to="loc_us-gaap_Liabilities_f0d03a6e-b6fc-4fce-8286-6255823eebdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b66241a1-77d1-40e4-95a5-ec4ff4295ee0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9e6771ca-201d-4e5e-8209-cef9fa30b9a5" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b66241a1-77d1-40e4-95a5-ec4ff4295ee0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_509e7fce-d19a-4fed-90d5-4b8e3dfd0f47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9e6771ca-201d-4e5e-8209-cef9fa30b9a5" xlink:to="loc_us-gaap_StockholdersEquity_509e7fce-d19a-4fed-90d5-4b8e3dfd0f47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2afad9ba-4811-4d45-96eb-de03c39e766e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_53f67c12-31b0-4e14-af73-64b89b95f852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2afad9ba-4811-4d45-96eb-de03c39e766e" xlink:to="loc_us-gaap_PreferredStockValue_53f67c12-31b0-4e14-af73-64b89b95f852" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c41c238d-3775-4b30-8834-431e0cfddcc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2afad9ba-4811-4d45-96eb-de03c39e766e" xlink:to="loc_us-gaap_CommonStockValue_c41c238d-3775-4b30-8834-431e0cfddcc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_621546fa-d1b1-4547-99db-dcf9ceb27105" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2afad9ba-4811-4d45-96eb-de03c39e766e" xlink:to="loc_us-gaap_AdditionalPaidInCapital_621546fa-d1b1-4547-99db-dcf9ceb27105" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_44b91a2a-85a9-4385-8df8-cd7581c635f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2afad9ba-4811-4d45-96eb-de03c39e766e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_44b91a2a-85a9-4385-8df8-cd7581c635f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_500583c2-4ae9-4e51-a318-d0191b4305fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2afad9ba-4811-4d45-96eb-de03c39e766e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_500583c2-4ae9-4e51-a318-d0191b4305fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_e4c12b93-2d10-47e4-a5fb-8a4bdc1da51b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2afad9ba-4811-4d45-96eb-de03c39e766e" xlink:to="loc_us-gaap_TreasuryStockValue_e4c12b93-2d10-47e4-a5fb-8a4bdc1da51b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_aad63bf1-718f-4302-bd84-0f5e170a4a25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_5d65b1d3-0d2f-473f-bef6-458a81ec211c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_aad63bf1-718f-4302-bd84-0f5e170a4a25" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_5d65b1d3-0d2f-473f-bef6-458a81ec211c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_962fc82a-9486-4358-ade3-f2a7da6ef006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_aad63bf1-718f-4302-bd84-0f5e170a4a25" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_962fc82a-9486-4358-ade3-f2a7da6ef006" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_404e7fbb-5170-4936-802e-920329e67bcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_379e6661-0296-4bf9-92f8-67e4dbece243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_404e7fbb-5170-4936-802e-920329e67bcc" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_379e6661-0296-4bf9-92f8-67e4dbece243" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_43275432-71b2-4e63-81a7-4d221f99a48e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_404e7fbb-5170-4936-802e-920329e67bcc" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_43275432-71b2-4e63-81a7-4d221f99a48e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e4fe0817-8453-4b52-9c2a-9e5c1d8aed89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_404e7fbb-5170-4936-802e-920329e67bcc" xlink:to="loc_us-gaap_InventoryNet_e4fe0817-8453-4b52-9c2a-9e5c1d8aed89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_378f4195-a97a-4d13-8ce4-b9dc584c0449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_404e7fbb-5170-4936-802e-920329e67bcc" xlink:to="loc_us-gaap_OtherAssetsCurrent_378f4195-a97a-4d13-8ce4-b9dc584c0449" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2cc777ce-d227-4c1e-8837-fddaab830f15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_11bc8fc2-b59d-46f2-bda3-82790ef85c04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2cc777ce-d227-4c1e-8837-fddaab830f15" xlink:to="loc_us-gaap_LiabilitiesCurrent_11bc8fc2-b59d-46f2-bda3-82790ef85c04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_9b20ffe4-6867-433d-ab41-f27d45470b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2cc777ce-d227-4c1e-8837-fddaab830f15" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_9b20ffe4-6867-433d-ab41-f27d45470b1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_cb017acb-9fb0-4e75-8790-d29c1f3963eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2cc777ce-d227-4c1e-8837-fddaab830f15" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_cb017acb-9fb0-4e75-8790-d29c1f3963eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_b59fd3c3-7876-45bc-8f6b-2a34563fc7e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2cc777ce-d227-4c1e-8837-fddaab830f15" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_b59fd3c3-7876-45bc-8f6b-2a34563fc7e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_be918861-7107-4a05-876d-173cdc06673d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2cc777ce-d227-4c1e-8837-fddaab830f15" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_be918861-7107-4a05-876d-173cdc06673d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_09c9e935-86b6-4c3e-adf6-bcb18b8f067e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2cc777ce-d227-4c1e-8837-fddaab830f15" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_09c9e935-86b6-4c3e-adf6-bcb18b8f067e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" xlink:type="simple" xlink:href="wst-20200930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="wst-20200930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60574978-8328-4100-9e8d-b1d2f457ca61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1ef45a79-305a-4565-b880-2af967d3f952" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60574978-8328-4100-9e8d-b1d2f457ca61" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1ef45a79-305a-4565-b880-2af967d3f952" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_246ec816-19ac-4b5e-baaf-cc0c2e8676b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60574978-8328-4100-9e8d-b1d2f457ca61" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_246ec816-19ac-4b5e-baaf-cc0c2e8676b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_ac2d8761-b925-40ec-b710-b6bf9ed3c114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60574978-8328-4100-9e8d-b1d2f457ca61" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_ac2d8761-b925-40ec-b710-b6bf9ed3c114" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_4c43d38b-0a6a-418b-a45f-a7f84badc967" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60574978-8328-4100-9e8d-b1d2f457ca61" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_4c43d38b-0a6a-418b-a45f-a7f84badc967" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a10a2f1b-a41a-42c1-9ad1-332b25969c23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2fbb5c49-42be-42bd-952c-541d6783153a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a10a2f1b-a41a-42c1-9ad1-332b25969c23" xlink:to="loc_us-gaap_NetIncomeLoss_2fbb5c49-42be-42bd-952c-541d6783153a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_84eb4211-4535-4772-aa66-01e4e6c635d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a10a2f1b-a41a-42c1-9ad1-332b25969c23" xlink:to="loc_us-gaap_Depreciation_84eb4211-4535-4772-aa66-01e4e6c635d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_2ebb55f4-df5c-4705-b85d-da8c7c4b4985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a10a2f1b-a41a-42c1-9ad1-332b25969c23" xlink:to="loc_us-gaap_AdjustmentForAmortization_2ebb55f4-df5c-4705-b85d-da8c7c4b4985" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_cbbadb13-0f64-48ab-8435-d3c42c1c5fb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a10a2f1b-a41a-42c1-9ad1-332b25969c23" xlink:to="loc_us-gaap_ShareBasedCompensation_cbbadb13-0f64-48ab-8435-d3c42c1c5fb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_407469a3-2e69-4736-9573-03e9c338de93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a10a2f1b-a41a-42c1-9ad1-332b25969c23" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_407469a3-2e69-4736-9573-03e9c338de93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_PensionSettlementCharge_70b81025-b357-4821-8c71-2ad29ecca36a" xlink:href="wst-20200930.xsd#wst_PensionSettlementCharge"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a10a2f1b-a41a-42c1-9ad1-332b25969c23" xlink:to="loc_wst_PensionSettlementCharge_70b81025-b357-4821-8c71-2ad29ecca36a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_127a1072-3a10-4f65-bad9-8a66b0223ecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a10a2f1b-a41a-42c1-9ad1-332b25969c23" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_127a1072-3a10-4f65-bad9-8a66b0223ecd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_cc990faf-43e1-48b5-b4ff-4ae62bf7559b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a10a2f1b-a41a-42c1-9ad1-332b25969c23" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_cc990faf-43e1-48b5-b4ff-4ae62bf7559b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_93b1c104-421f-425c-baa3-a993c10879d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a10a2f1b-a41a-42c1-9ad1-332b25969c23" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_93b1c104-421f-425c-baa3-a993c10879d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8b4d69d0-3ad4-4ebe-9b16-d9c726b59bb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_58ece4fb-2b43-45ca-be20-2284c643add2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8b4d69d0-3ad4-4ebe-9b16-d9c726b59bb4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_58ece4fb-2b43-45ca-be20-2284c643add2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7cc34e23-b159-4ccf-ab67-846400378c64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8b4d69d0-3ad4-4ebe-9b16-d9c726b59bb4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7cc34e23-b159-4ccf-ab67-846400378c64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5736d53d-b97d-41ea-8ff1-83a1dcd20b31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8b4d69d0-3ad4-4ebe-9b16-d9c726b59bb4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5736d53d-b97d-41ea-8ff1-83a1dcd20b31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c0c48ed6-2b3e-457b-8ae1-664539df1885" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8b4d69d0-3ad4-4ebe-9b16-d9c726b59bb4" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c0c48ed6-2b3e-457b-8ae1-664539df1885" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa60d515-81d5-46a5-9fef-18595d7d3bf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_c8ed53d0-95c2-4830-970a-eea029a1ad7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa60d515-81d5-46a5-9fef-18595d7d3bf2" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_c8ed53d0-95c2-4830-970a-eea029a1ad7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_43cc6ffd-dd9f-4f41-96f0-2f0d948a98b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa60d515-81d5-46a5-9fef-18595d7d3bf2" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_43cc6ffd-dd9f-4f41-96f0-2f0d948a98b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_0437cddc-9763-4df0-b4f2-b193f7847db7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa60d515-81d5-46a5-9fef-18595d7d3bf2" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_0437cddc-9763-4df0-b4f2-b193f7847db7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_2e77021e-cb3b-40d2-9514-b9d91984baf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa60d515-81d5-46a5-9fef-18595d7d3bf2" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_2e77021e-cb3b-40d2-9514-b9d91984baf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_8228aa8b-d39c-403d-b5ce-492765b83aa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa60d515-81d5-46a5-9fef-18595d7d3bf2" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_8228aa8b-d39c-403d-b5ce-492765b83aa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_053e7a6d-d889-41e0-a481-7e5dbff7d723" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa60d515-81d5-46a5-9fef-18595d7d3bf2" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_053e7a6d-d889-41e0-a481-7e5dbff7d723" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_223e3861-f099-4b42-aab5-6d190c40a6cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa60d515-81d5-46a5-9fef-18595d7d3bf2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_223e3861-f099-4b42-aab5-6d190c40a6cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8e6453db-9bf7-457c-bf22-eaae0299806a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa60d515-81d5-46a5-9fef-18595d7d3bf2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8e6453db-9bf7-457c-bf22-eaae0299806a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="wst-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="wst-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NewAccountingStandards" xlink:type="simple" xlink:href="wst-20200930.xsd#NewAccountingStandards"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/NewAccountingStandards" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NewAccountingStandardsDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#NewAccountingStandardsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/NewAccountingStandardsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/Revenue" xlink:type="simple" xlink:href="wst-20200930.xsd#Revenue"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/Revenue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueTables" xlink:type="simple" xlink:href="wst-20200930.xsd#RevenueTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#RevenueRevenueRecognitionDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueRevenueRecognitionDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueContractsandLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#RevenueContractsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueContractsandLiabilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#RevenueContractsandLiabilitiesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueContractsandLiabilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_d83016e0-ad1b-46b6-8ea7-95ded0573f97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_6a76a456-1424-4eee-8020-38663213d31b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractWithCustomerLiability_d83016e0-ad1b-46b6-8ea7-95ded0573f97" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_6a76a456-1424-4eee-8020-38663213d31b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_3d0db499-8506-4df9-acf1-d34e913b249b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractWithCustomerLiability_d83016e0-ad1b-46b6-8ea7-95ded0573f97" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_3d0db499-8506-4df9-acf1-d34e913b249b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#RevenueSupplyChainFinancingDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueSupplyChainFinancingDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/RevenueVoluntaryRecallDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#RevenueVoluntaryRecallDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/RevenueVoluntaryRecallDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShare" xlink:type="simple" xlink:href="wst-20200930.xsd#NetIncomePerShare"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareTables" xlink:type="simple" xlink:href="wst-20200930.xsd#NetIncomePerShareTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#NetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4aceb7ac-67d8-47c5-9836-d18578aa003c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_91e79455-fd0b-478b-8f63-c9fc1eccee55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4aceb7ac-67d8-47c5-9836-d18578aa003c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_91e79455-fd0b-478b-8f63-c9fc1eccee55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7d9bec7a-0a5d-4281-89f1-8e3dea90b739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4aceb7ac-67d8-47c5-9836-d18578aa003c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7d9bec7a-0a5d-4281-89f1-8e3dea90b739" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/Inventories" xlink:type="simple" xlink:href="wst-20200930.xsd#Inventories"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/Inventories" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/InventoriesTables" xlink:type="simple" xlink:href="wst-20200930.xsd#InventoriesTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/InventoriesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/InventoriesDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_72001c93-701c-4e4d-b3a3-69321c99e3fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2fc51c9b-929b-4c71-8400-c9147e42c364" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_72001c93-701c-4e4d-b3a3-69321c99e3fe" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2fc51c9b-929b-4c71-8400-c9147e42c364" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_23e1e08b-7429-487e-9b52-b3c5bca806e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_72001c93-701c-4e4d-b3a3-69321c99e3fe" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_23e1e08b-7429-487e-9b52-b3c5bca806e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d236833f-32fe-49ee-b748-7d408ebc2e3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_72001c93-701c-4e4d-b3a3-69321c99e3fe" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d236833f-32fe-49ee-b748-7d408ebc2e3f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/Leases" xlink:type="simple" xlink:href="wst-20200930.xsd#Leases"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesTables" xlink:type="simple" xlink:href="wst-20200930.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#LeasesLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_e29b2094-d503-428d-817f-94fd4d375157" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_1fa239cb-d61c-4616-ac07-ef5d612dfe6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_e29b2094-d503-428d-817f-94fd4d375157" xlink:to="loc_us-gaap_OperatingLeaseCost_1fa239cb-d61c-4616-ac07-ef5d612dfe6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_2536e53f-8e7e-4020-a5de-3aaccfdde5c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_e29b2094-d503-428d-817f-94fd4d375157" xlink:to="loc_us-gaap_ShortTermLeaseCost_2536e53f-8e7e-4020-a5de-3aaccfdde5c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_1040c998-4f9b-454c-8b58-44313e112a45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_e29b2094-d503-428d-817f-94fd4d375157" xlink:to="loc_us-gaap_VariableLeaseCost_1040c998-4f9b-454c-8b58-44313e112a45" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#LeasesLeaseCashFlowandSupplementalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesLeaseCashFlowandSupplementalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#LeasesLeaseWeightedAverageDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesLeaseWeightedAverageDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d6aea585-3697-4f4f-bd93-c71b5c93463e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f3729a5a-5bd7-4096-acd7-82a320c58f04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d6aea585-3697-4f4f-bd93-c71b5c93463e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f3729a5a-5bd7-4096-acd7-82a320c58f04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ef83d8bf-9d81-4a03-81fe-57d0669bd14a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d6aea585-3697-4f4f-bd93-c71b5c93463e" xlink:to="loc_us-gaap_OperatingLeaseLiability_ef83d8bf-9d81-4a03-81fe-57d0669bd14a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="wst-20200930.xsd#LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97750e7f-5d11-414f-9f5a-3d7b410133d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_462ac04b-7c57-4ba5-88d5-eab0e8f0bcd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97750e7f-5d11-414f-9f5a-3d7b410133d3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_462ac04b-7c57-4ba5-88d5-eab0e8f0bcd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1b85c033-fdc8-4cf9-8378-7195b62f156b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97750e7f-5d11-414f-9f5a-3d7b410133d3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1b85c033-fdc8-4cf9-8378-7195b62f156b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8fb2511a-c2ce-403b-a6d7-9fa9ea603278" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97750e7f-5d11-414f-9f5a-3d7b410133d3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8fb2511a-c2ce-403b-a6d7-9fa9ea603278" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_457e32f6-577f-4a85-bc3f-ab28ea745505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97750e7f-5d11-414f-9f5a-3d7b410133d3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_457e32f6-577f-4a85-bc3f-ab28ea745505" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ccb9e730-02e0-4a7a-9776-bd2f82e98616" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97750e7f-5d11-414f-9f5a-3d7b410133d3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ccb9e730-02e0-4a7a-9776-bd2f82e98616" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0930eafa-adb4-47ae-852f-efee46bfb585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97750e7f-5d11-414f-9f5a-3d7b410133d3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0930eafa-adb4-47ae-852f-efee46bfb585" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_966a65fb-334a-4492-9334-4d0f1f8a1ff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97750e7f-5d11-414f-9f5a-3d7b410133d3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_966a65fb-334a-4492-9334-4d0f1f8a1ff7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_6290ffd9-5ea7-4601-87e5-ec3993db5387" xlink:href="wst-20200930.xsd#wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_97750e7f-5d11-414f-9f5a-3d7b410133d3" xlink:to="loc_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_6290ffd9-5ea7-4601-87e5-ec3993db5387" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompanies" xlink:type="simple" xlink:href="wst-20200930.xsd#AffiliatedCompanies"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompanies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AffiliatedCompaniesDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#AffiliatedCompaniesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AffiliatedCompaniesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/Debt" xlink:type="simple" xlink:href="wst-20200930.xsd#Debt"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/Debt" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtTables" xlink:type="simple" xlink:href="wst-20200930.xsd#DebtTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DebtTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtLongtermDebtDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#DebtLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DebtLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_cab05b6e-66a2-48ee-b17e-e4a390b886bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_6dd6ad6a-0919-43d2-9bec-61bfade05cf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_cab05b6e-66a2-48ee-b17e-e4a390b886bf" xlink:to="loc_us-gaap_LongTermDebtCurrent_6dd6ad6a-0919-43d2-9bec-61bfade05cf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_e01af691-11f2-4598-b067-673cf7d00b8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_cab05b6e-66a2-48ee-b17e-e4a390b886bf" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_e01af691-11f2-4598-b067-673cf7d00b8a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtLongtermDebtDetails_1" xlink:type="simple" xlink:href="wst-20200930.xsd#DebtLongtermDebtDetails_1"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DebtLongtermDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ef4d5e5e-4e11-4e98-bec3-1d38183e42af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_b8c9699d-9604-43a2-ba2f-106334481aa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ef4d5e5e-4e11-4e98-bec3-1d38183e42af" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_b8c9699d-9604-43a2-ba2f-106334481aa4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c42e699f-0528-41d3-bc67-eec5a02e89a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ef4d5e5e-4e11-4e98-bec3-1d38183e42af" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_c42e699f-0528-41d3-bc67-eec5a02e89a1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtCreditAgreementDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#DebtCreditAgreementDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DebtCreditAgreementDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="wst-20200930.xsd#DerivativeFinancialInstruments"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstruments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="wst-20200930.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsForeignExchangeRateRiskDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_644124b9-71bb-4eb2-90c8-261881421c10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_e6548c3c-efb8-4be8-ba0b-a65486b74bba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_644124b9-71bb-4eb2-90c8-261881421c10" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_e6548c3c-efb8-4be8-ba0b-a65486b74bba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_1eeab8aa-96ba-463a-a38f-2ef32b8fb792" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_644124b9-71bb-4eb2-90c8-261881421c10" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_1eeab8aa-96ba-463a-a38f-2ef32b8fb792" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_b65c0078-d300-4077-8833-521c49e594ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_644124b9-71bb-4eb2-90c8-261881421c10" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_b65c0078-d300-4077-8833-521c49e594ea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="wst-20200930.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="wst-20200930.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_7d93bf4c-2635-4da6-a30f-76bd48613e0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_92eef0e1-0ad4-4abb-a07d-2034ed776bf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_7d93bf4c-2635-4da6-a30f-76bd48613e0e" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_92eef0e1-0ad4-4abb-a07d-2034ed776bf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_ad5f84a7-d968-4bd3-bcbf-455eb0e034d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_7d93bf4c-2635-4da6-a30f-76bd48613e0e" xlink:to="loc_us-gaap_DerivativeAssets_ad5f84a7-d968-4bd3-bcbf-455eb0e034d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_5a8a3a32-e20d-40c1-a4d2-3b99cea2450f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_7d93bf4c-2635-4da6-a30f-76bd48613e0e" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_5a8a3a32-e20d-40c1-a4d2-3b99cea2450f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_fae5d80d-fad9-465a-844c-da69ea160871" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_5044969c-c3c9-4e8b-b668-fce556e7aec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_fae5d80d-fad9-465a-844c-da69ea160871" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_5044969c-c3c9-4e8b-b668-fce556e7aec3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a450cee9-c72a-4775-a0b6-b49e9e64236c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_fae5d80d-fad9-465a-844c-da69ea160871" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_a450cee9-c72a-4775-a0b6-b49e9e64236c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_d3e29231-3f3e-417e-b584-363fd954ef8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_fae5d80d-fad9-465a-844c-da69ea160871" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_d3e29231-3f3e-417e-b584-363fd954ef8a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementLevel3FairValueMeasurementsDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#FairValueMeasurementLevel3FairValueMeasurementsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementLevel3FairValueMeasurementsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementOtherFinancialInstrumentsDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#FairValueMeasurementOtherFinancialInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementOtherFinancialInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="wst-20200930.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="wst-20200930.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9af34e4f-66cf-43ff-9c28-2bcf066524da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_d978cc5d-86fe-43ca-a0b5-b31f396c8efc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9af34e4f-66cf-43ff-9c28-2bcf066524da" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_d978cc5d-86fe-43ca-a0b5-b31f396c8efc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_f0415759-4509-44ab-ab5a-3c26fc7f2644" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9af34e4f-66cf-43ff-9c28-2bcf066524da" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_f0415759-4509-44ab-ab5a-3c26fc7f2644" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossOtherComprehensiveLossReclassificationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="wst-20200930.xsd#ShareholdersEquity"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/ShareholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="wst-20200930.xsd#ShareholdersEquityTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/ShareholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#ShareholdersEquityChangeinShareholdersEquityDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/ShareholdersEquityChangeinShareholdersEquityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/ShareholdersEquitySupplementalEquityInformationDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#ShareholdersEquitySupplementalEquityInformationDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/ShareholdersEquitySupplementalEquityInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="wst-20200930.xsd#StockBasedCompensation"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/StockBasedCompensationDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#StockBasedCompensationDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/StockBasedCompensationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlans" xlink:type="simple" xlink:href="wst-20200930.xsd#BenefitPlans"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansTables" xlink:type="simple" xlink:href="wst-20200930.xsd#BenefitPlansTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansScheduleofComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#BenefitPlansScheduleofComponentsofNetPeriodicBenefitCostDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansScheduleofComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9d5f39fa-5c8c-4f91-8f04-a0830809233f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_0c1cc3fe-5b2a-4647-bcf9-fc5226bc485d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9d5f39fa-5c8c-4f91-8f04-a0830809233f" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_0c1cc3fe-5b2a-4647-bcf9-fc5226bc485d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_2c9b6f3c-47f5-40d2-8c46-bf2fb73cee8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9d5f39fa-5c8c-4f91-8f04-a0830809233f" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_2c9b6f3c-47f5-40d2-8c46-bf2fb73cee8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_fea2052a-b081-477b-8529-faf651dc5934" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9d5f39fa-5c8c-4f91-8f04-a0830809233f" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_fea2052a-b081-477b-8529-faf651dc5934" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_5191de35-0c4e-4e2c-a119-cd93d308afff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9d5f39fa-5c8c-4f91-8f04-a0830809233f" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_5191de35-0c4e-4e2c-a119-cd93d308afff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_4f681cef-1dec-420d-b9c5-58b0763219ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9d5f39fa-5c8c-4f91-8f04-a0830809233f" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_4f681cef-1dec-420d-b9c5-58b0763219ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_4624a4fc-55d3-4901-990e-b525dcd657f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_9d5f39fa-5c8c-4f91-8f04-a0830809233f" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_4624a4fc-55d3-4901-990e-b525dcd657f6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/BenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#BenefitPlansNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/BenefitPlansNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncome" xlink:type="simple" xlink:href="wst-20200930.xsd#OtherExpenseIncome"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncome" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeTables" xlink:type="simple" xlink:href="wst-20200930.xsd#OtherExpenseIncomeTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeOtherExpenseIncomeDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#OtherExpenseIncomeOtherExpenseIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeOtherExpenseIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_2d7c1d27-f958-464d-89fb-8e58cd6db1c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_381b4181-e56a-4008-9dd4-04c2c600e5f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_2d7c1d27-f958-464d-89fb-8e58cd6db1c7" xlink:to="loc_us-gaap_SeveranceCosts1_381b4181-e56a-4008-9dd4-04c2c600e5f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_7f20e205-2fd2-4ad2-8696-fc2efd06c457" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_2d7c1d27-f958-464d-89fb-8e58cd6db1c7" xlink:to="loc_us-gaap_AssetImpairmentCharges_7f20e205-2fd2-4ad2-8696-fc2efd06c457" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_10876f36-2efc-4ecc-926d-6ce17e9c4481" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_2d7c1d27-f958-464d-89fb-8e58cd6db1c7" xlink:to="loc_us-gaap_OtherRestructuringCosts_10876f36-2efc-4ecc-926d-6ce17e9c4481" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_eae459b5-9902-434e-aca5-9d006a31aa64" xlink:href="wst-20200930.xsd#wst_OtherIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_9a3842d3-19c6-45cd-8005-5a668881c8ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_eae459b5-9902-434e-aca5-9d006a31aa64" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_9a3842d3-19c6-45cd-8005-5a668881c8ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_d5af3aa4-7e86-4ad2-9d15-4c88e39c0e53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionLossBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_eae459b5-9902-434e-aca5-9d006a31aa64" xlink:to="loc_us-gaap_ForeignCurrencyTransactionLossBeforeTax_d5af3aa4-7e86-4ad2-9d15-4c88e39c0e53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetImpairmentCharges_a5b76e8a-c845-4de2-b6f5-3009db501db2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetImpairmentCharges"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_eae459b5-9902-434e-aca5-9d006a31aa64" xlink:to="loc_us-gaap_OtherAssetImpairmentCharges_a5b76e8a-c845-4de2-b6f5-3009db501db2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_DevelopmentAndLicensingIncome_82fb3014-407c-4394-b821-99e928f05e9e" xlink:href="wst-20200930.xsd#wst_DevelopmentAndLicensingIncome"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_eae459b5-9902-434e-aca5-9d006a31aa64" xlink:to="loc_wst_DevelopmentAndLicensingIncome_82fb3014-407c-4394-b821-99e928f05e9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_05698dae-22e9-4dcd-a1e2-5e970799d42b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_eae459b5-9902-434e-aca5-9d006a31aa64" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_05698dae-22e9-4dcd-a1e2-5e970799d42b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_3281eddf-0ff7-4287-8137-ae818849130d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_eae459b5-9902-434e-aca5-9d006a31aa64" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_3281eddf-0ff7-4287-8137-ae818849130d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_2a87dfb1-89ec-4183-95f7-9ae22c5ba7c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_eae459b5-9902-434e-aca5-9d006a31aa64" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_2a87dfb1-89ec-4183-95f7-9ae22c5ba7c1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeRestructuringandRelatedChargesDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#OtherExpenseIncomeRestructuringandRelatedChargesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeRestructuringandRelatedChargesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeDevelopmentandLicensingIncomeDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#OtherExpenseIncomeDevelopmentandLicensingIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeDevelopmentandLicensingIncomeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxes" xlink:type="simple" xlink:href="wst-20200930.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#IncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/IncomeTaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="wst-20200930.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformation" xlink:type="simple" xlink:href="wst-20200930.xsd#SegmentInformation"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SegmentInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="wst-20200930.xsd#SegmentInformationTables"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SegmentInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="wst-20200930.xsd#SegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SegmentInformationDetails" xlink:type="extended"/>
</link:linkbase>
